Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4283124
Max Phase: Preclinical
Molecular Formula: C27H27NO2
Molecular Weight: 397.52
Molecule Type: Small molecule
Associated Items:
ID: ALA4283124
Max Phase: Preclinical
Molecular Formula: C27H27NO2
Molecular Weight: 397.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc2occ(-c3ccccc3)c2c(C)c1-c1ccc(CN2CCOCC2)cc1
Standard InChI: InChI=1S/C27H27NO2/c1-19-16-25-27(24(18-30-25)22-6-4-3-5-7-22)20(2)26(19)23-10-8-21(9-11-23)17-28-12-14-29-15-13-28/h3-11,16,18H,12-15,17H2,1-2H3
Standard InChI Key: AHIWPTORZUITES-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 397.52 | Molecular Weight (Monoisotopic): 397.2042 | AlogP: 6.22 | #Rotatable Bonds: 4 |
Polar Surface Area: 25.61 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 7.19 | CX LogP: 6.18 | CX LogD: 5.97 |
Aromatic Rings: 4 | Heavy Atoms: 30 | QED Weighted: 0.41 | Np Likeness Score: -0.52 |
1. Fang C, Lee KK, Nietupski R, Bates RH, Fernandez-Menendez R, Lopez-Roman EM, Guijarro-Lopez L, Yin Y, Peng Z, Gomez JE, Fisher S, Barros-Aguirre D, Hubbard BK, Serrano-Wu MH, Hung DT.. (2018) Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors., 28 (22): [PMID:30316633] [10.1016/j.bmcl.2018.09.037] |
Source(1):